Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 1/2 1

Status

Completed 28Unknown 15Terminated 5Not yet recruiting 3Recruiting 2

Sponsor Class

OTHER 5INDUSTRY 3NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Polycystic Ovary Syndrome 2Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lung Neoplasms 1Hyperbilirubinemia 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × OTHER × Folic Acid × Clear all
NCT03564678 2025-09-05

Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 2 Terminated
10 enrolled 5 charts
LymphoidOther hematologic neoplasm

Hyperbilirubinemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04881851 2025-04-16

IALA

Universita di Verona

Phase NA Terminated
76 enrolled

Polycystic Ovary Syndrome

NCT00402883 2021-11-09

Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

SCRI Development Innovations, LLC

Phase 2 Terminated
5 enrolled 6 charts
Thoracic

Lung Neoplasms

NCT02221154 2017-06-16

FIV-INOPK

Centre Hospitalier Departemental Vendee

Phase 4 Terminated
49 enrolled

Polycystic Ovary Syndrome

NCT00220532 2006-09-13

Folate and Protection Against Cervical Cancer

Sheffield Teaching Hospitals NHS Foundation Trust

Phase 1/2 Terminated
180 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡